Posted by Michael Wonder on 21 Jun 2018
Price disclosure 2018 October cycle outcomes summary
21 June 2018 - The summary of price disclosure price reductions for the 2018 October Cycle (Fifth Remove Originator cycle) has now been published.
This summary only includes medicines taking a price disclosure reduction on 1 October 2018. The determined price disclosure outcomes for this cycle were calculated in accordance with the National Health Act 1953 (the Act) as amended and National Health (Pharmaceutical Benefits) Regulations 2017 (the Regulations) in force currently.
The outcomes below show percentage (%) price differences and ex‑manufacturer level prices. They do not include fees and mark-ups. Information about publication of prices including fees and mark-ups.
